Janux Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-17.0M | $-18.5M | $1.5M | $6.9M |
| FY2022 | $-42.9M | $-49.4M | $6.4M | $17.2M |
| FY2023 | $-50.6M | $-52.4M | $1.9M | $20.0M |
| FY2024 | $-43.8M | $-44.2M | $359.0K | $33.0M |
| FY2025 | $-82.2M | $-83.3M | $1.0M | $40.2M |